GlassScriptPhysician profile
Oliver A Mckee
NPI 1366440042
$3,172.99
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $622 · 2020: $396 · 2021: $618 · 2022: $744 · 2023: $793.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $779 · Education: $14.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $779.06 |
| Education | $14.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,450.92 | 2019-2023 | |
| Pfizer INC. | $385.30 | 2019-2023 | |
| Amgen INC. | $293.40 | 2020-2023 | Otezla |
| Journey Medical Corporation | $248.91 | 2019-2023 | |
| Leo Pharma INC. | $107.55 | 2022-2023 | Adbry |
| Prugen, INC. Pharmaceuticals | $106.83 | 2019-2020 | |
| Galderma Laboratories, L.P. | $96.26 | 2019-2021 | |
| Genzyme Corporation | $80.78 | 2019-2023 | |
| Dermavant Sciences, INC. | $69.11 | 2023 | Vtama |
| Janssen Biotech, INC. | $59.24 | 2023 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $49.70 | 2023 | Libtayo, Dupixent |
| Merz North America, INC. | $37.06 | 2023 | Xeomin |
| Lilly USA, LLC | $35.43 | 2023 | Taltz, Olumiant |
| E.R. Squibb & Sons, L.L.C. | $35.42 | 2023 | Sotyktu |
| Mayne Pharma Commercial LLC | $35.31 | 2019-2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $32.64 | 2019-2022 | |
| Celgene Corporation | $14.92 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.78 | 2021 | |
| Aclaris Therapeutics, INC. | $11.40 | 2019 | |
| Epi Health, LLC | $11.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oliver Mckee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.